EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures

Ahead of an FDA de­ci­sion date lat­er this year, Lex­i­con Phar­ma­ceu­ti­cals is trim­ming its work­force. The com­pa­ny will lay off rough­ly half of its sales

Brus­sels-based bio­phar­ma com­pa­ny UCB con­firmed Thurs­day that it de­cid­ed not to re­new its mem­ber­ship in the in­dus­try group BIO in 2024, the sec­ond high-pro­file ex­it

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug